21.04.2017
- US pharmaceutical companies Bristol-Myers Squibb and Apexigen are collaborating to test a combination of their respective drugs to treat patients with advanced solid tumors...
08.03.2017
- After losing three earlier lawsuits alleging that its talc powder caused ovarian cancer – which cost it nearly $200 million in damages – US healthcare giant Johnson & Johnson (J&J)...
06.03.2017
- Britain's health agency National Institute for Health and Care Excellence (NICE), which has responsibility for assessing the cost-effectiveness of medical treatments, has decided...
03.03.2017
- Cancer Research UK, its commercial arm Cancer Research Technology (CRT) and Chinese life science company HitGen have entered into a license agreement to develop a novel class of...
22.02.2017
- Chinese drugmaker Qilu Pharmaceutical has introduced a new targeted therapy generic cancer medicine, geftinib, which is claimed to be effective against non-small cell lung cancer...
21.02.2017
- AstraZeneca has agreed to sell the commercial rights for its cancer treatment Zoladex in the US and Canada for $250 million upfront to private equity-backed TerSera Therapeutics –...
16.02.2017
- The UK’s Tusk Therapeutics is joining Cancer Research Technology (CRT) and University College London (UCL) to research, develop and commercialize an antibody-based therapeutic...
10.02.2017
- US biomedical company Q BioMed has entered into an agreement with the Oklahoma Medical Research Foundation (OMRF) and India’s Rajiv Gandhi Centre for Biotechnology to develop a...
